Participants lost an average of 17% of their body weight in nine months, which is remarkable as its typically more difficult for type 2 diabetics to lose weight compared to others with obesity or who are overweight
[DOI] [PubMed] [Google Scholar] 40.Marso S.P., Daniels G.H., Brown-Frandsen K., Kristensen P., Mann J.F.E., Nauck M.A., Nissen S.E., Pocock S., Poulter N.R., Ravn L.S., et al
Neuronal AKAP150 coordinates PKA and Epac-mediated PKB/Akt phosphorylation
These include semaglutide, exenatide, liraglutide, and dulaglutide
Noom reports 70% of members experience no side effects versus higher rates with full-dose treatment, potentially improving medication adherence and allowing patients to stick with their treatment plans longer
However, these effects are usually mild and tend to improve over time